Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Puma Biotechnology Inc - Common Stock (NQ:PBYI)

2.900 +0.070 (+2.47%)
Streaming Delayed Price Updated: 2:13 PM EDT, Apr 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 204,257
Open 2.890
Bid (Size) 2.890 (9)
Ask (Size) 2.900 (12)
Prev. Close 2.830
Today's Range 2.820 - 2.935
52wk Range 2.225 - 6.055
Shares Outstanding 47,509,765
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025
From Puma Biotechnology, Inc.
Via Business Wire

Performance

YTD
-7.1%
-7.1%
1 Month
-15.3%
-15.3%
3 Month
-18.3%
-18.3%
6 Month
+9.0%
+9.0%
1 Year
-48.5%
-48.5%

More News

Read More
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Puma Biotechnology, Inc.
Via Business Wire
Earnings Scheduled For February 27, 2025
Via Benzinga
Where Puma Biotechnology Stands With Analysts
Via Benzinga
Beyond The Numbers: 4 Analysts Discuss Puma Biotechnology Stock
Via Benzinga
Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology to Present at TD Cowen’s 45th Annual Health Care Conference
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology Reports Third Quarter 2024 Financial Results
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
From Puma Biotechnology, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology Reports Second Quarter Financial Results
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Puma Biotechnology, Inc.
Via Business Wire

Frequently Asked Questions

Is Puma Biotechnology Inc - Common Stock publicly traded?
Yes, Puma Biotechnology Inc - Common Stock is publicly traded.
What exchange does Puma Biotechnology Inc - Common Stock trade on?
Puma Biotechnology Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Puma Biotechnology Inc - Common Stock?
The ticker symbol for Puma Biotechnology Inc - Common Stock is PBYI on the Nasdaq Stock Market
What is the current price of Puma Biotechnology Inc - Common Stock?
The current price of Puma Biotechnology Inc - Common Stock is 2.900
When was Puma Biotechnology Inc - Common Stock last traded?
The last trade of Puma Biotechnology Inc - Common Stock was at 04/08/25 02:13 PM ET
What is the market capitalization of Puma Biotechnology Inc - Common Stock?
The market capitalization of Puma Biotechnology Inc - Common Stock is 137.77M
How many shares of Puma Biotechnology Inc - Common Stock are outstanding?
Puma Biotechnology Inc - Common Stock has 138M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.